PAK2 is an effector of TSC1/2 signaling independent of mTOR and a potential therapeutic target for Tuberous Sclerosis ComplexMaria M. Alves, Maikel P. Peppelenbosch|Scientific Reports|2015Cited by 47
Genetic screening of Congenital Short Bowel Syndrome patients confirms CLMP as the major gene involved in the recessive form of this disorderMaria M. Alves, Robert M.W. Hofstra, Reza Maroofian et al.|European Journal of Human Genetics|2016Cited by 24
The long Filamin-A isoform is required for intestinal development and motility: implications for chronic intestinal pseudo-obstructionAlmira Zada, Maria M. Alves|Human Molecular Genetics|2022Cited by 16
A combinatorial panel for flow cytometry‐based isolation of enteric nervous system cells from human intestineJonathan D. Windster, Maria M. Alves|EMBO Reports|2023Cited by 15